Literature DB >> 11090120

Effects of castration on contraction and alpha(1)-adrenoceptor expression in rat prostate.

Y Homma1, K Hamada, Y Nakayama, G Tsujimoto, K Kawabe.   

Abstract

1. The prostate function is regulated by androgens and alpha-adrenergic activity. Clinically, antiandrogens and/or alpha(1)-adrenergic antagonists are commonly used to treat symptomatic prostatic hypertrophy. To elucidate the effects of androgen deprivation on prostate contractility via alpha(1)-adrenoceptor, the characteristics and expression of alpha(1)-adrenoceptors were examined in castrated rats. 2. Isolated prostate strips from intact and castrated rats were subjected to a phenylephrine stimulated contraction. Prazosin (10 nM), [(3)H]-prazosin and phenoxybenzamine (3 - 300 nM) were used for inhibition assay, receptor characterization and partial alkylation of alpha-adrenoceptor, respectively. The mRNA content of three subtypes of alpha-adrenoceptors was determined by reverse transcription combined with polymerase chain reaction (RT - PCR). 3. Contractile response to phenylephrine increased in castrated rats, which could be explained by a relative increase of the stromal component. A lowered contraction potency was also noted in castrated rats. Receptor binding assay indicated minimal changes in the affinity or density of alpha(1)-adrenoceptor. Escalating alkylation of the alpha(1)-adrenoceptor population resulted in a rightward shift in the contraction-response curves before depressing maximal contractile force, and the suppression was detected at lower doses in castrated rats. RT - PCR study confirmed the expression of three types of alpha(1)-adrenoceptor, alpha(1a), alpha(1b) and alpha(1d)-adrenoceptors, in intact rat prostate, and revealed that alpha(1a)-adrenoceptor, but not alpha(1b) or alpha(1d)-adrenoceptors, was down-regulated in castrates. 4. The results show that androgen deprivation suppressed alpha(1)-adrenergic contractility of rat prostate strips, and the suppression was associated with down-regulation of receptor reserve for the alpha(1a)-adreneroceptor population expressed in intact rat prostate.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11090120      PMCID: PMC1572464          DOI: 10.1038/sj.bjp.0703706

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  40 in total

1.  Binding and functional characterization of alpha1-adrenoceptor subtypes in the rat prostate.

Authors:  Y Hiraoka; T Ohmura; M Oshita; Y Watanabe; K Morikawa; O Nagata; H Kato; T Taniguchi; I Muramatsu
Journal:  Eur J Pharmacol       Date:  1999-01-29       Impact factor: 4.432

2.  Comparative alpha-1 adrenoceptor subtype selectivity and functional uroselectivity of alpha-1 adrenoceptor antagonists.

Authors:  D J Martin; P Lluel; E Guillot; A Coste; D Jammes; I Angel
Journal:  J Pharmacol Exp Ther       Date:  1997-07       Impact factor: 4.030

3.  Tamsulosin and chlormadinone for the treatment of benign prostatic hyperplasia. The Kobe University YM617 Study Group.

Authors:  H Okada; N Kawaida; T Ogawa; S Arakawa; O Matsumoto; S Kamidono
Journal:  Scand J Urol Nephrol       Date:  1996-10

Review 4.  Alpha-adrenergic approach in the medical management of benign prostatic hyperplasia.

Authors:  P Mátyus; K Horváth
Journal:  Med Res Rev       Date:  1997-11       Impact factor: 12.944

5.  Quantification and distribution of alpha 1-adrenoceptor subtype mRNAs in human prostate: comparison of benign hypertrophied tissue and non-hypertrophied tissue.

Authors:  K Nasu; N Moriyama; K Kawabe; G Tsujimoto; M Murai; T Tanaka; J Yano
Journal:  Br J Pharmacol       Date:  1996-11       Impact factor: 8.739

6.  Alpha1-adrenoceptors in testosterone-induced prostatic hypertrophy.

Authors:  L Auger-Pourmarin; P Roubert; P E Chabrier
Journal:  Eur J Pharmacol       Date:  1998-01-02       Impact factor: 4.432

7.  Chronology and urodynamic characterization of micturition in neurohormonally induced experimental prostate growth in the rat.

Authors:  J Z Lee; S Omata; B Tillig; I Perkash; C E Constantinou
Journal:  Neurourol Urodyn       Date:  1998       Impact factor: 2.696

8.  Noradrenaline contractions of human prostate mediated by alpha 1A-(alpha 1c-) adrenoceptor subtype.

Authors:  I Marshall; R P Burt; C R Chapple
Journal:  Br J Pharmacol       Date:  1995-07       Impact factor: 8.739

9.  The efficacy of terazosin, finasteride, or both in benign prostatic hyperplasia. Veterans Affairs Cooperative Studies Benign Prostatic Hyperplasia Study Group.

Authors:  H Lepor; W O Williford; M J Barry; M K Brawer; C M Dixon; G Gormley; C Haakenson; M Machi; P Narayan; R J Padley
Journal:  N Engl J Med       Date:  1996-08-22       Impact factor: 91.245

10.  Localization and expression of the alpha1A-1, alpha1B and alpha1D-adrenoceptors in hyperplastic and non-hyperplastic human prostate.

Authors:  P D Walden; C Gerardi; H Lepor
Journal:  J Urol       Date:  1999-02       Impact factor: 7.450

View more
  6 in total

1.  Postnatal androgen deprivation dissociates the development of smooth muscle innervation from functional neurotransmission in mouse vas deferens.

Authors:  J A Brock; D J Handelsman; J R Keast
Journal:  J Physiol       Date:  2007-03-22       Impact factor: 5.182

Review 2.  Phenotype pharmacology of lower urinary tract α(1)-adrenoceptors.

Authors:  A Nishimune; H Yoshiki; J Uwada; A S M Anisuzzaman; H Umada; I Muramatsu
Journal:  Br J Pharmacol       Date:  2012-03       Impact factor: 8.739

3.  Testosterone regulates smooth muscle contractile pathways in the rat prostate: emphasis on PDE5 signaling.

Authors:  Xinhua Zhang; Ning Zang; Yu Wei; Jin Yin; Ruobing Teng; Allen Seftel; Michael E Disanto
Journal:  Am J Physiol Endocrinol Metab       Date:  2011-10-25       Impact factor: 4.310

4.  Nandrolone treatment decreases the level of rat kidney alpha(1B)-adrenoceptors.

Authors:  Staffan Uhlén; Jonas Lindblom; Anna Kindlundh; Paul Mugisha; Fred Nyberg
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2003-07-12       Impact factor: 3.000

Review 5.  Alpha1-, alpha2- and beta-adrenoceptors in the urinary bladder, urethra and prostate.

Authors:  Martin C Michel; Wim Vrydag
Journal:  Br J Pharmacol       Date:  2006-02       Impact factor: 8.739

6.  Functional and structural changes in internal pudendal arteries underlie erectile dysfunction induced by androgen deprivation.

Authors:  Rh Ure Alves-Lopes; Karla B Neves; Marcondes Ab Silva; Vânia C Olivon; Silvia G Ruginsk; José Antunes-Rodrigues; Leandra Nz Ramalho; Rita C Tostes; Fernando Silva Carneiro
Journal:  Asian J Androl       Date:  2017 Sep-Oct       Impact factor: 3.285

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.